Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medicine. Caution urged on SARS vaccines.

× No keyword cloud information.

45 in total

1. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.

Authors: Meagan Bolles; Damon Deming; Kristin Long; Sudhakar Agnihothram; Alan Whitmore; Martin Ferris; William Funkhouser; Lisa Gralinski; Allison Totura; Mark Heise; Ralph S Baric
Journal: J Virol Date: 2011-09-21 Impact factor: 5.103

2. Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization.

Authors: Wing-pui Kong; Ling Xu; Konrad Stadler; Jeffrey B Ulmer; Sergio Abrignani; Rino Rappuoli; Gary J Nabel
Journal: J Virol Date: 2005-11 Impact factor: 5.103

3. Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus.

Authors: Yuxian He; Yusen Zhou; Pamela Siddiqui; Jinkui Niu; Shibo Jiang
Journal: J Clin Microbiol Date: 2005-08 Impact factor: 5.948

4. Innovation and challenges in funding rapid research responses to emerging infectious diseases: Lessons learned from the outbreak of severe acute respiratory syndrome.

Authors: Bhagirath Singh
Journal: Can J Infect Dis Med Microbiol Date: 2004-05 Impact factor: 2.471

5. Application of siRNA against SARS in the rhesus macaque model.

Authors: Qingquan Tang; Baojian Li; Martin Woodle; Patrick Y Lu
Journal: Methods Mol Biol Date: 2008

6. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.

Authors: Yuxian He; Jingjing Li; Susanne Heck; Sara Lustigman; Shibo Jiang
Journal: J Virol Date: 2006-06 Impact factor: 5.103

7. Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine.

Authors: Natalia Pogrebnyak; Maxim Golovkin; Vyacheslav Andrianov; Sergei Spitsin; Yuriy Smirnov; Richard Egolf; Hilary Koprowski
Journal: Proc Natl Acad Sci U S A Date: 2005-06-14 Impact factor: 11.205

8. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.

Authors: Xiaofen Zhong; Huanghao Yang; Zu-Feng Guo; Wan-Yee Fion Sin; Wei Chen; Junjie Xu; Ling Fu; Jie Wu; Chun-Kit Gannon Mak; Chak-Sum Samuel Cheng; Yanzhen Yang; Shuyong Cao; Tin-Yau Wong; Sik-To Lai; Yong Xie; Zhihong Guo
Journal: J Virol Date: 2005-03 Impact factor: 5.103

9. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.

Authors: Lanying Du; Guangyu Zhao; Yongping Lin; Hongyan Sui; Chris Chan; Selene Ma; Yuxian He; Shibo Jiang; Changyou Wu; Kwok-Yung Yuen; Dong-Yan Jin; Yusen Zhou; Bo-Jian Zheng
Journal: J Immunol Date: 2008-01-15 Impact factor: 5.422

10. Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors: Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal: Virus Res Date: 2007-04-09 Impact factor: 3.303